MedPath

Alacrity Biosciences, Inc.

Alacrity Biosciences, Inc. logo
🇺🇸United States
Ownership
Private
Employees
1
Market Cap
-
Website
http://www.alacritybio.com

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

A Study of ALTY-0501 for the Treatment of Dry Eye Administered 4 Times a Day for a 56 Day Period

Phase 2
Completed
Conditions
Dry Eye
Interventions
Drug: placebo
First Posted Date
2007-02-23
Last Posted Date
2007-10-02
Lead Sponsor
Alacrity Biosciences, Inc.
Target Recruit Count
160
Registration Number
NCT00439400
Locations
🇺🇸

Ophthalmic Research Associates, Andover, Massachusetts, United States

News

No news found
© Copyright 2025. All Rights Reserved by MedPath